Emotion recognition in early Parkinson's disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants

Emotion recognition in early Parkinson's disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants

Parkinson’s disease (PD) is traditionally regarded as a neurodegenerative movement disorder, however, nigrostriatal dopaminergic degeneration is also thought to disrupt non-motor loops connecting basal ganglia to areas in frontal cortex involved in cognition and emotion processing. PD patients are i...

Full description

Bibliographic Details
Main Authors:	Lindsey G. McIntosh, Sishir eMannava, Corrie R Camalier, Brad S. Folley, Aaron eAlbritton, Peter E. Konrad, David eCharles, Sohee ePark, Joseph eNeimat
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-01-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Dopamine Levodopa emotion recognition DBS healthy aging early-stage Parkinson's disease
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00349/full

Similar Items

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
by: Angelo Antonini
Published: (2009-05-01)

Deep brain stimulation in Tourette's Syndrome
by: Avram eFraint, et al.
Published: (2015-08-01)

Deep Brain Stimulation and Treatment Outcomes of Young- and Late-Onset (≤55 Years) Parkinson's Disease: A Population-Based Study
by: Emanuele Camerucci, et al.
Published: (2021-12-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)

Subthalamic Nucleus Long-Range Synchronization – an Independent Hallmark of Human Parkinson's disease
by: Shay eMoshel, et al.
Published: (2013-11-01)

Systematic Evaluation of DBS Parameters in the Hemi-Parkinsonian Rat Model
by: Soheil Mottaghi, et al.
Published: (2020-10-01)

Encoding type, medication, and deep brain stimulation differentially affect memory-guided sequential reaching movements in Parkinson's disease
by: Fabian J. David, et al.
Published: (2022-10-01)

Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease
by: Muthuraman Muthuraman, et al.
Published: (2018-08-01)

EEG Microstates Change in Response to Increase in Dopaminergic Stimulation in Typical Parkinson’s Disease Patients
by: J. Ignacio Serrano, et al.
Published: (2018-10-01)

Disturbances in body ownership in schizophrenia: evidence from the rubber hand illusion and case study of a spontaneous out-of-body experience.
by: Katharine N Thakkar, et al.
Published: (2011-01-01)

Women's preferences for attributes of first-trimester miscarriage management: a stated preference discrete-choice experiment
by: Petrou, S, et al.
Published: (2009)

Dialing up the danger: Virtual reality for the simulation of risk
by: Verity McIntosh, et al.
Published: (2022-08-01)

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
by: Yi ZM, et al.
Published: (2018-04-01)

Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication
by: Johanna M. Nagel, et al.
Published: (2023-01-01)

Peri-lead edema and local field potential correlation in post-surgery subthalamic nucleus deep brain stimulation patients
by: Marco Prenassi, et al.
Published: (2022-09-01)

Theory of mind deficits in Parkinson’s disease are not modulated by dopaminergic medication
by: Tatiana Usnich, et al.
Published: (2023-09-01)

Inflammasome, the Constitutive Heterochromatin Machinery, and Replication of an Oncogenic Herpesvirus
by: Sumita Bhaduri-McIntosh, et al.
Published: (2021-05-01)

Erratum: Theory of mind deficits in Parkinson's disease are not modulated by dopaminergic medication
by: Frontiers Production Office
Published: (2023-12-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Optimal Parameters of Deep Brain Stimulation in Essential Tremor: A Meta-Analysis and Novel Programming Strategy
by: I. Daria Bogdan, et al.
Published: (2020-06-01)

Authenticity, depression and deep brain stimulation
by: Veronica eJohansson, et al.
Published: (2011-05-01)

Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease
by: Francesco Cavallieri, et al.
Published: (2021-02-01)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
by: Milap Anil Nowrangi, et al.
Published: (2015-01-01)

Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment
by: Gustav Cedergren Weber, et al.
Published: (2023-08-01)

Clinical characteristics of dopa ⁃ responsive dystonia
by: Wei SONG, et al.
Published: (2011-02-01)

Developments in Deep Brain Stimulators for Successful Aging Towards Smart Devices—An Overview
by: Angelito A. Silverio, et al.
Published: (2022-04-01)

Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome
by: Reiff Julia, et al.
Published: (2011-09-01)

Economic evaluation. Part 2: frameworks for combining costs and benefits in health care.
by: McIntosh, E, et al.
Published: (2006)

Estimating the costs of surgical innovations: the case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease.
by: McIntosh, E, et al.
Published: (2003)

Erratum: Economic evaluation. Part 1: Introduction to the concepts of economic evaluation in health care (Journal of Family Planning and Reproductive Health Care (2006) 32, 2 (107-112))
by: McIntosh, E, et al.
Published: (2006)

What reasons do those with practical experience use in deciding on priorities for healthcare resources? A qualitative study.
by: Hasman, A, et al.
Published: (2008)

Economic evaluation. Part 1: Introduction to the concepts of economic evaluation in health care.
by: McIntosh, E, et al.
Published: (2006)

Chronic haloperidol administration downregulates select BDNF transcript and protein levels in the dorsolateral prefrontal cortex of rhesus monkeys
by: Scott E. Hemby, et al.
Published: (2023-02-01)

Effect of a staffing strategy based on voluntary increase in working hours on quality of patient care in a hospital in KwaZulu-Natal
by: J. McIntosh, et al.
Published: (2009-09-01)

Closing the loop of deep brain stimulation
by: Romain eCARRON, et al.
Published: (2013-12-01)

Increased metabolic activity in the septum and habenula during stress is linked to subsequent expression of learned helplessness behavior
by: Martine M Mirrione, et al.
Published: (2014-02-01)

Influence of intra-abomasal administration of L-DOPA on circulating catecholamines and feed intake in cattle
by: Eriton E. L. Valente, et al.
Published: (2023-02-01)

Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation Escala para qualidade de vida na doença de Parkinson - PDQ 39 (versão do Português falado no Brasil) como instrumento para avaliação de pacientes com e sem flutuação motora decorrente da levodopa
by: Renata Guzzo Souza, et al.
Published: (2007-09-01)

The role of astroglia in the antidepressant action of deep brain stimulation
by: Adeline eEtiévant, et al.
Published: (2016-01-01)

Less Pulsatile Levodopa Therapy (6 Doses Daily) Is Associated with a Reduced Incidence of Dyskinesia
by: Mark M. Lin, et al.
Published: (2019-01-01)